These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 32281612)
21. Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis. Fernández-Carballido C; Navarro-Compán V; Castillo-Gallego C; Castro-Villegas MC; Collantes-Estévez E; de Miguel E; Arthritis Care Res (Hoboken); 2017 Jan; 69(1):150-155. PubMed ID: 27111872 [TBL] [Abstract][Full Text] [Related]
22. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis. Tsang HHL; Chung HY J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926 [TBL] [Abstract][Full Text] [Related]
23. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Zochling J Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S47-58. PubMed ID: 22588768 [No Abstract] [Full Text] [Related]
25. Correlations among quality of life, spinal mobility, and disease activity in early-treated axial spondyloarthritis: a single-center cross-sectional study. Khampaen T; Kafaksom T; Dechapaphapitak N; Tongdee N; Chevaisrakul P BMC Rheumatol; 2024 Oct; 8(1):54. PubMed ID: 39415300 [TBL] [Abstract][Full Text] [Related]
26. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis? Kilic G; Kilic E; Ozgocmen S Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497 [TBL] [Abstract][Full Text] [Related]
27. Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial. Sieper J; Landewé R; Rudwaleit M; van der Heijde D; Dougados M; Mease PJ; Braun J; Deodhar A; Kivitz A; Walsh J; Hoepken B; Nurminen T; Maksymowych WP Arthritis Rheumatol; 2015 Mar; 67(3):668-77. PubMed ID: 25470228 [TBL] [Abstract][Full Text] [Related]
28. Gender difference in ASAS HI among patients with ankylosing spondylitis. Chen HH; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Huang WN; Chen YH PLoS One; 2020; 15(7):e0235678. PubMed ID: 32645080 [TBL] [Abstract][Full Text] [Related]
29. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore. Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage. López-Medina C; Garrido-Castro JL; Castro-Jiménez J; González-Navas C; Calvo-Gutiérrez J; Castro-Villegas MC; Ortega-Castro R; Escudero-Contreras A; Font-Ugalde P; Collantes-Estévez E Clin Rheumatol; 2018 Jun; 37(6):1581-1588. PubMed ID: 29691772 [TBL] [Abstract][Full Text] [Related]
31. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637 [TBL] [Abstract][Full Text] [Related]
32. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Salaffi F; De Angelis R; Carotti M; Gutierrez M; Sarzi-Puttini P; Atzeni F Rheumatol Int; 2014 Aug; 34(8):1103-10. PubMed ID: 24509896 [TBL] [Abstract][Full Text] [Related]
33. [Comparison of clinical manifestations according to HLA-B(27) genotype in ankylosing spondylitis patients: real-world evidence from smart management system for spondyloarthritis]. Ji XJ; Sun K; Hu ZY; Zhang Y; Ma YP; Sun Z; Li KP; Zhu J; Zhang JL; Huang F Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):179-184. PubMed ID: 29518861 [No Abstract] [Full Text] [Related]
34. [The clinical analysis for the whole-spine magnetic resonance imaging of axial spondyloarthritis]. Luo G; Zhao Z; Zhu J; Zhang J; Huang F Zhonghua Nei Ke Za Zhi; 2014 Jun; 53(6):464-8. PubMed ID: 25146515 [TBL] [Abstract][Full Text] [Related]
35. Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Taylor AL; Balakrishnan C; Calin A Arthritis Rheum; 1998 Jun; 41(6):1119-25. PubMed ID: 9627023 [TBL] [Abstract][Full Text] [Related]
36. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort. Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497 [TBL] [Abstract][Full Text] [Related]
37. Gender characterization in a large series of Brazilian patients with spondyloarthritis. de Carvalho HM; Bortoluzzo AB; Gonçalves CR; da Silva JA; Ximenes AC; Bértolo MB; Ribeiro SL; Keiserman M; Menin R; Skare TL; Carneiro S; Azevedo VF; Vieira WP; Albuquerque EN; Bianchi WA; Bonfiglioli R; Campanholo C; Costa IP; Duarte AP; Gavi MB; Kohem CL; Leite NH; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Sampaio-Barros PD; Clin Rheumatol; 2012 Apr; 31(4):687-95. PubMed ID: 22203094 [TBL] [Abstract][Full Text] [Related]
38. Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry. Bodur H; Yurdakul FG; Ataman S; Cay HF; Gurer G; Capkin E; Sezer İ; Duruoz MT; Melikoglu MA; Rezvani A; Yagci I; Gogus F; Kamanli A; Akgul O; Cevik R Clin Rheumatol; 2022 Jul; 41(7):2053-2063. PubMed ID: 35353263 [TBL] [Abstract][Full Text] [Related]
39. Risk of falls in patients with ankylosing spondylitis. Dursun N; Sarkaya S; Ozdolap S; Dursun E; Zateri C; Altan L; Birtane M; Akgun K; Revzani A; Aktas İ; Tastekin N; Celiker R J Clin Rheumatol; 2015 Mar; 21(2):76-80. PubMed ID: 25710858 [TBL] [Abstract][Full Text] [Related]
40. Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis. Biallas RL; Dean LE; Davidson L; Hollick R; Pathan E; Robertson L; Jones GT; Macfarlane GJ; Rotariu O Arthritis Care Res (Hoboken); 2022 Apr; 74(4):665-674. PubMed ID: 33140891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]